Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 133 participants.
Also called NCT02072161
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 133 participants
- Registry
-
NCT02072161
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02072161. Randomized; quadruple masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2015-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- ETC-1002
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Statin Therapy
- Lead sponsor
- Esperion Therapeutics, Inc.
- Collaborator
- Medpace, Inc.
Record details
- Record id
cardio:ct-nct02072161- Content hash
4a383ff87da275dacb5cd2968cc5d42216f72ad44ef2545ab0294511ad1a7ea6